Prevention of Adriamycin-induced full-thickness skin loss using hyaluronidase infiltration

Plastic and Reconstructive Surgery

Volumn 101, Issue 2, 1998, Pages 370-374

  Disa, Joseph J ^a   Chang, Raymond R ^a   Mucci, Samuel J ^a   Goldberg, Nelson H ^a,b  

^a UNIVERSITY OF MARYLAND MEDICAL SYSTEM   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; HYALURONIDASE; VINBLASTINE; VINCRISTINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXTRAVASATION; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN DEFECT; SKIN IRRITATION; SKIN ULCER;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; HUMANS; HYALURONOGLUCOSAMINIDASE; MALE; RATS; RATS, SPRAGUE-DAWLEY; SKIN; SKIN ULCER;

EID: 0031908712     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-199802000-00016     Document Type: Article

References (26)

1. Brown, A. S., Hoelzer, D. J., and Piercy, S. A. Skin necrosis from extravasation of intravenous fluids in children. Plast. Reconstr. Surg. 64: 145, 1979.
2. Riyami, A. Complications of intravenous infusions. J. Ir. Med. Assoc. 61: 23, 1968.
3. Ignoffo, R. J., and Friedmann, M. A. Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs. Cancer Treat. Rev. 7: 17, 1980.
4. Heckler, F. R. Current thoughts on extravasation injuries. Clin. Plast. Surg. 16: 557, 1989.
5. Harwood, K., and Aisner, J. Treatment of chemotherapy extravasation: Current status. Cancer Treat. Rep. 68: 939, 1984.
6. Hagan, H. J., III, and Hastings, H. Extravasation of phenytoin in the hand. J. Hand Surg. 13A: 942, 1988.
7. MacCara, M. E. Extravasation: A hazard of intravenous therapy. Drug Intell. Clin. Pharm. 17: 713, 1983.
8. Rudolph, R., Stein, R. S., and Pattillo, R. A. Skin ulcers due to Adriamycin. Cancer 38: 1087, 1976.
9. Luedke, D. W., Kennedy, P. S., and Rietschel, R. E. Histopathogenesis of skin and subcutaneous injury induced by Adriamycin. Plast. Reconstr. Surg. 63: 463, 1979.
10. Rudolph, R., Woodward, M., and Hurn, I. Ultrastructure of doxorubicin (Adriamycin) induced skin necrosis in rats. Cancer Res. 39: 3689, 1979.
11. Silvestrini, R., Gambarucci, D., and Desdia, T. Attivita biologica dell Adriamicina in vitro. Tumori 56: 137, 1970.
12. Zweig, J. I., Kabakow, B., Wallach, R. C., et.al. Rational effective medical treatment of skin ulcers due to Adriamycin. Cancer Treat. Rep. 63: 2101, 1979.
13. Larson, D. L. What is the appropriate management of tissue extravasation by antitumor agents? Plast. Reconstr. Surg. 75: 397, 1985.
14. Upton, J., Mulliken, J. B., and Murray, J. E. Major intravenous extravasation injuries. Am. J. Surg. 137: 497, 1979.
15. Bowers, D. G., Jr., and Lynch, J. B. Adriamycin extravasation. Plast. Reconstr. Surg. 61: 86, 1978.
16. Svingen, B. A., Powis, G., Appel, P. L., et al. Protection against Adriamycin induced skin necrosis in the rat by dimethyl sulfoxide and alpha tocopherol. Cancer Res. 41: 395, 1981.
17. Desai, M. H., and Teres, D. Prevention of doxorubicin-induced skin ulcers in the rat and pig with dimethyl sulfoxide (DMSO). Cancer Treat. Rep. 66: 1371, 1982.
18. Dorr, R. T., Alberts, D. S., and Chen, H. S. G. The limited role of corticosteroids in ameliorating experimental doxorubicin skin toxicity in the mouse. Cancer Chemother. Pharmacol. 5: 17, 1980.
19. Dorr, R. T., and Alberts, D. S. Failure of DMSO and vitamin E to prevent doxorubicin skin ulceration in the mouse. Cancer Treat. Rep. 67: 499, 1983.
20. Loth, T. S., and Eversmann, W. W., Jr. Treatment methods for extravasations of chemotherapeutic agents: A comparative study. J. Hand Surg. 11A: 388, 1986.
21. Dorr, R. T. What is the appropriate management of tissue extravasation by and tumor agents? (Discussion). Plast. Reconstr. Surg. 75: 403, 1985.
22. Linder, R. M., Upton, J., and Osteen, R. Management of extensive doxorubicin hydrochloride extravasation injuries. J. Hand Surg. 8: 33, 1983.
23. Larson, D. L. Treatment of tissue extravasation by antitumor agents. Cancer 49: 1796, 1982.
24. Larson, D. L. Alterations in wound healing secondary to infusion injury. Clin. Plast. Surg. 17: 509, 1990.
25. Montrose, P. Extravasation management. Semin. Oncol. Nurs. 3: 128, 1987.
26. Mucci, S. J., Crist, K. A., Chaudhuri, B., et al. Pharmacokinetics of doxorubicin during isolated perfusion: The effect of heparin on doxorubicin concentration. Reg. Cancer Treat. 4: 110, 1991.